Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;100:940-942
doi: 10.1161/01.RES.0000265134.57140.da
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heximer, S.
Right arrow Articles by Husain, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heximer, S.
Right arrow Articles by Husain, M.
(Circulation Research. 2007;100:940.)
© 2007 American Heart Association, Inc.


Editorials

A Candidate Hypertension Gene

Will SPON1 Hold Salt and Water?

Scott Heximer, Mansoor Husain

From the Heart and Stroke Richard Lewar Centre for Excellence in Cardiovascular Research (S.H., M.H.) and the Departments of Physiology (S.H., M.H.) Medicine, Laboratory Medicine and Pathobiology (M.H.), University of Toronto, Canada.

Correspondence to Mansoor Husain, MD, 200 Elizabeth St, TMDT 3-909, Toronto, ON, Canada M5G-2C4. E-mail mansoor.husain@utoronto.ca



See related article, pages 992–999


Key Words: hypertension • genetics • animal models • vascular biology


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Hypertension affects >20% of the general population, and yet its etiologic basis remains unknown in the vast proportion of those affected.1 Hypertension greatly increases the risk of stroke, myocardial infarction, congestive heart failure and renal dysfunction thus making it an important focus of clinical research. Although pharmacological reductions in blood pressure have been shown to decrease the incidence of these adverse consequences,2 large numbers of hypertensive patients go undiagnosed, undertreated, or are nonresponsive to lifestyle modifications and medical therapy.1 As such, there remains a pressing need for an improved understanding of the mechanisms underlying hypertension.

Recent advances in genomic and proteomic analyses have led to the discovery of Mendelian forms (monogenetic traits) of hypertension.3,4 Although rare, these mutations which mainly involve altered renal salt handling, provide a molecular basis for understanding the critical role of the kidney during normal blood pressure regulation.5 By contrast, our understanding of the relative contributions of kidney, heart, CNS, and blood vessel function to blood pressure variations in the general population is complicated by the fact that spontaneous hypertension typically arises as a complex quantitative trait affected by differing combinations of genetic and environmental factors. A number of quantitative trait loci (QTL) associated with hypertension have been identified in both animal disease models and human patients, however the affected gene(s) at these sites have remained elusive owing to the large size and complexity of the regions identified.6 The use of congenic rodent strains to reduce the genomic size of QTLs is an important advance in . . . [Full Text of this Article]